Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
23.87
+0.82 (+3.54%)
Streaming Delayed Price
Updated: 11:51 AM EDT, Apr 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of
April 17, 2025
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...
Via
StockStory
Eli Lilly Stock Rockets On Weight-Loss Pill Progress
April 17, 2025
Eli Lilly's pill-form weight loss drug cansdidate cleared one of several Phase III hurdles.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Product Safety
Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars
April 17, 2025
Eli Lilly's oral GLP-1 drug orforglipron met key Phase 3 goals in type 2 diabetes, lowering A1C and weight with a favorable safety profile.
Via
Benzinga
Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now
April 17, 2025
Tariff uncertainty has created an ideal opportunity for long-term investors to pounce.
Via
The Motley Fool
Topics
Economy
Government
Stocks
Exposures
Economy
Interest Rates
Political
Mr. Ethan Billings recommends paying close attention to biotech stocks
April 17, 2025
Via
Binary News Network
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
April 16, 2025
From
Pfizer Inc.
Via
Business Wire
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
April 16, 2025
Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...
Via
Benzinga
Topics
Government
Exposures
Political
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
April 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
April 16, 2025
By Meg Flippin Benzinga
Via
TheNewswire.com
Exposures
Product Safety
Will Pfizer Approach Viking Therapeutics With A Buyout Proposa
April 15, 2025
Investors are running into Viking Therapeutics this week after an incident of drug-induced liver injury pushed Pfizer into terminating the development of its weight-loss pill.
Via
Talk Markets
Topics
Stocks / Equities
Why Pfizer Stock Topped the Market on Tuesday
April 15, 2025
Via
The Motley Fool
Exposures
COVID-19
Most active S&P500 stocks in Tuesday's session
April 15, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study
April 15, 2025
Novavax updated Covid vaccine showed fewer and milder side effects than Pfizer-BioNTech's in a Utah study.
Via
Benzinga
Exposures
COVID-19
Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight-Loss Pill?
April 15, 2025
Via
The Motley Fool
Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish
April 15, 2025
Investors are now considering the possibility of Pfizer acquiring either of these companies as it looks for external candidates.
Via
Stocktwits
Top Analyst Reports For Bank Of America, Chevron & Stryker
April 14, 2025
Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation, Chevron Corporation, and Stryker Corporation, as well as two micro-cap stocks, Value...
Via
Talk Markets
Topics
Stocks / Equities
What's going on in today's session: S&P500 most active stocks
April 14, 2025
Let's have a look at what is happening on the US markets on Monday. Below you can find the most active S&P500 stocks in today's session.
Via
Chartmill
This Strategy Always Outperforms In Bear Markets
April 14, 2025
Via
Benzinga
Trump’s Trade Twist Sends Stocks Soaring
April 14, 2025
Stocks are firmly higher Monday, as a surprise tariff exemption from President Donald Trump sparked a rally in the tech sector.
Via
Talk Markets
Topics
Government
Stocks / Equities
World Trade
Exposures
Political
Tariff
Novo Nordisk Warns Against Counterfeit Ozempic In US: Retail’s Unmoved
April 14, 2025
The company said the seized counterfeit products feature lot number PAR0362 and illegitimate serial numbers beginning with the first eight digits, 51746517.
Via
Stocktwits
Topics
Economy
Exposures
Product Safety
Supply Chain
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
April 14, 2025
Pfizer bows, but is not entirely out of the GLP-1 race.
Via
The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
April 14, 2025
Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.
Via
Benzinga
Meta’s Antitrust Trial Over Instagram, WhatsApp Acquisition To Begin Today: Chief Legal Officer Says FTC’s Case ‘Ignores Reality’
April 14, 2025
The social media giant acquired Instagram in 2012 for $1 billion and WhatsApp in a highly competitive bid in 2014 for a whopping $19 billion, beating Google to the punch.
Via
Stocktwits
Topics
Government
Lawsuit
Exposures
Financial
Legal
Political
Breaking New Study: mRNA Vaccines Trigger 620% Heart Risk Surge in Young Men
April 14, 2025
A groundbreaking study published in the International Journal of Cardiovascular Research & Innovation reveals alarming long-term heart risks linked to COVID-19 mRNA vaccines, challenging official...
Via
Newsworthy
Exposures
COVID-19
Pfizer Discontinues Once-Daily Weight Loss Pill Over Liver Injury In One Patient
April 14, 2025
Pfizer has ended development of danuglipron, an oral GLP-1 drug for weight management, citing clinical data and regulatory input.
Via
Benzinga
Starbucks Updates Dress Code For Baristas To Offer Consistent Experience
April 14, 2025
Baristas must wear a solid black top and a denim bottom in any shade of khaki, blue, or black.
Via
Stocktwits
Topics
Workforce
Exposures
Layoff
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered
April 14, 2025
The company plans to file a certification of dissolution with the Secretary of the State of Delaware in the third quarter of 2025, provided that stockholders authorize the decision at its annual...
Via
Stocktwits
Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient
April 14, 2025
According to Pfizer, the reported patient’s liver enzymes “recovered rapidly” after they stopped taking the company’s experimental weight loss pill.
Via
Stocktwits
Topics
Government
Exposures
Political
Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
April 14, 2025
The company is continuing to test a daily pill that blocks GIPR.
Via
Investor's Business Daily
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
April 14, 2025
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.